Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-13 4:10 pm Purchase |
2023-11-01 | 13G | VYNE Therapeutics Inc. VYNE |
Eventide Asset Management, LLC | 1,394,336 9.990% |
1,394,336 (New Position) |
Filing History |
| 2023-11-13 2:43 pm Purchase |
2023-10-31 | 13G | Xometry, Inc. XMTR |
Eventide Asset Management, LLC | 5,730,339 12.650% |
5,730,339 (New Position) |
Filing History |
| 2023-10-10 3:40 pm Purchase |
2023-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Eventide Asset Management, LLC | 7,814,039 11.070% |
7,814,039 (New Position) |
Filing History |
| 2023-02-14 3:04 pm Unchanged |
2022-12-31 | 13G | Vital Farms, Inc. VITL |
Eventide Asset Management, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 3:00 pm Sale |
2022-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Eventide Asset Management, LLC | 0 0.000% |
-2,708,975 (Position Closed) |
Filing History |
| 2023-02-14 2:50 pm Sale |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
Eventide Asset Management, LLC | 0 0.000% |
-3,318,647 (Position Closed) |
Filing History |
| 2023-02-14 2:37 pm Unchanged |
2022-12-31 | 13G | Zymeworks Inc. ZYME |
Eventide Asset Management, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 2:06 pm Purchase |
2022-12-31 | 13G | VectivBio Holding AG VECT |
Eventide Asset Management, LLC | 3,405,644 5.400% |
1,066,600 (+45.60%) |
Filing History |
| 2023-02-14 1:58 pm Sale |
2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Eventide Asset Management, LLC | 1,032,938 2.200% |
-2,709,569 (-72.40%) |
Filing History |
| 2023-02-14 1:54 pm Purchase |
2022-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Eventide Asset Management, LLC | 394,718 9.100% |
162,341 (+69.86%) |
Filing History |
| 2023-02-14 1:48 pm Sale |
2022-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Eventide Asset Management, LLC | 2,589,778 3.700% |
-925,131 (-26.32%) |
Filing History |
| 2023-02-14 1:40 pm Purchase |
2022-12-31 | 13G | Annexon, Inc. ANNX |
Eventide Asset Management, LLC | 3,626,508 7.600% |
776,508 (+27.25%) |
Filing History |
| 2023-02-14 1:38 pm Sale |
2022-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Eventide Asset Management, LLC | 234,537 7.500% |
-19,502 (-7.68%) |
Filing History |
| 2023-02-14 1:36 pm Sale |
2022-12-31 | 13G | KnowBe4, Inc. KNBE |
Eventide Asset Management, LLC | 0 0.000% |
-4,177,983 (Position Closed) |
Filing History |
| 2023-02-14 1:34 pm Purchase |
2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 2,057,000 5.600% |
2,057,000 (New Position) |
Filing History |
| 2023-02-14 1:32 pm Purchase |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Eventide Asset Management, LLC | 3,150,000 6.600% |
3,150,000 (New Position) |
Filing History |
| 2023-02-14 1:30 pm Purchase |
2022-12-31 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 2,251,368 6.300% |
2,251,368 (New Position) |
Filing History |
| 2023-02-14 1:24 pm Purchase |
2022-12-31 | 13G | 908 Devices Inc. MASS |
Eventide Asset Management, LLC | 2,230,665 7.000% |
2,230,665 (New Position) |
Filing History |
| 2022-02-14 12:04 pm Purchase |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Eventide Asset Management, LLC | 2,629,593 7.600% |
201,617 (+8.30%) |
Filing History |
| 2022-02-14 12:01 pm Purchase |
2021-12-31 | 13G | Vital Farms, Inc. VITL |
Eventide Asset Management, LLC | 2,950,000 7.300% |
896,768 (+43.68%) |
Filing History |